{"id":778,"date":"2022-02-08T14:55:15","date_gmt":"2022-02-08T13:55:15","guid":{"rendered":"https:\/\/www.icta.fr\/?page_id=778"},"modified":"2024-02-14T10:27:41","modified_gmt":"2024-02-14T09:27:41","slug":"etudes-de-cas","status":"publish","type":"page","link":"https:\/\/www.icta.fr\/fr\/etudes-de-cas\/","title":{"rendered":"Etudes de cas"},"content":{"rendered":"\n<section class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-70d46135\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<h2 class=\"wp-block-heading has-text-align-center is-style-paragraphsmall\">D\u00e9couvrez dans cette s\u00e9lection d&#8217;\u00e9tudes de cas quelques exemples de solutions mises en oeuvre pour relever les d\u00e9fis<br> de projets complexes et parfois atypiques<\/h2>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-color uagb-block-b30aa6f3 carousselhome newshover\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">        <div class=\"wp-block-getwid-custom-post-type custom-post-type-casclients has-layout-grid has-spacing-none carrouselhome casehover\">\n            <div class=\"wp-block-getwid-custom-post-type__wrapper getwid-columns getwid-columns-2\">\n                \t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/a-first-in-human-trial-of-monoclonal-antibody-imp-in-patients-with-anti-mullerian-hormone-receptor-ii-amhrii-positive-gynecological-cancers\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/gynecologic-cancer-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"A First-In-Human trial of monoclonal antibody IMP in patients with Anti-M\u00fcllerian-Hormone-Receptor II (AMHRII) positive gynecological cancers\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/a-first-in-human-trial-of-monoclonal-antibody-imp-in-patients-with-anti-mullerian-hormone-receptor-ii-amhrii-positive-gynecological-cancers\/\">A First-In-Human trial of monoclonal antibody IMP in patients with Anti-M\u00fcllerian-Hormone-Receptor II (AMHRII) positive gynecological cancers<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/lung-cancer-patients-treated-with-a-new-pd-1-imp-a-longitudinal-prospective-observational-multicentric-study-in-france\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/lung-cancer-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"Lung cancer patients treated with a new PD-1 IMP: A longitudinal, prospective, observational, multicentric study in France\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/lung-cancer-patients-treated-with-a-new-pd-1-imp-a-longitudinal-prospective-observational-multicentric-study-in-france\/\">Lung cancer patients treated with a new PD-1 IMP: A longitudinal, prospective, observational, multicentric study in France<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/a-prospective-study-on-an-imp-pet-ct-imaging-in-biochemical-recurrence-of-prostate-cancer\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/petct-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"A Prospective study on an IMP PET\/CT Imaging in Biochemical Recurrence of Prostate Cancer\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/a-prospective-study-on-an-imp-pet-ct-imaging-in-biochemical-recurrence-of-prostate-cancer\/\">A Prospective study on an IMP PET\/CT Imaging in Biochemical Recurrence of Prostate Cancer<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/pain-relief-and-protection-of-three-self-treated-dermatological-foot-conditions\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/foot-dermatological-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"Pain relief and protection of three self-treated dermatological foot conditions\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/pain-relief-and-protection-of-three-self-treated-dermatological-foot-conditions\/\">Pain relief and protection of three self-treated dermatological foot conditions<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/open-non-controlled-parallel-cohorts-multicenter-phase-2a-trial-for-the-evaluation-of-the-antitumor-activity-of-an-imp-single-agent-and-in-combination-with-chemotherapy-in-patients-with-locally-ad\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/chemotherapy-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/open-non-controlled-parallel-cohorts-multicenter-phase-2a-trial-for-the-evaluation-of-the-antitumor-activity-of-an-imp-single-agent-and-in-combination-with-chemotherapy-in-patients-with-locally-ad\/\">Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/derived-cell-atmp-implantation-for-the-treatment-of-fecal-incontinence-a-multicentre-randomized-double-blind-placebo-controlled-parallel-group-dose-finding-clinical-study\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/fecal-incontinence-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"Derived cell ATMP implantation for the treatment of fecal incontinence: a multicentre, randomized, double-blind, placebo-controlled, parallel-group, dose-finding clinical study.\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/derived-cell-atmp-implantation-for-the-treatment-of-fecal-incontinence-a-multicentre-randomized-double-blind-placebo-controlled-parallel-group-dose-finding-clinical-study\/\">Derived cell ATMP implantation for the treatment of fecal incontinence: a multicentre, randomized, double-blind, placebo-controlled, parallel-group, dose-finding clinical study.<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/a-phase-1-2-open-label-safety-tolerability-and-preliminary-efficacy-study-of-implantation-into-one-eye-of-an-atmp-in-patients-with-retinitis-pigmentosa-due-to-monogenic-mutation\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/Retinitis-Pigmentosa-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"A phase 1\/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of an ATMP in patients with retinitis pigmentosa due to monogenic mutation\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/a-phase-1-2-open-label-safety-tolerability-and-preliminary-efficacy-study-of-implantation-into-one-eye-of-an-atmp-in-patients-with-retinitis-pigmentosa-due-to-monogenic-mutation\/\">A phase 1\/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of an ATMP in patients with retinitis pigmentosa due to monogenic mutation<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/long-term-safety-evaluation-of-a-medicinal-product-in-inherited-haematological-disorder-in-europe\/\">\n        <img decoding=\"async\" width=\"240\" height=\"145\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/haematological-disorder-240x145.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"Long-Term Safety Evaluation of a Medicinal Product in Inherited Haematological Disorder in Europe\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/long-term-safety-evaluation-of-a-medicinal-product-in-inherited-haematological-disorder-in-europe\/\">Long-Term Safety Evaluation of a Medicinal Product in Inherited Haematological Disorder in Europe<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class='wp-block-getwid-custom-post-type__post'>\n\t\t\t\t\t\t\t\t\t\n<div class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-undefined uagb-block-215f4ffe evtgroup\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:44%\">\n<div class=\"wp-block-getwid-template-post-featured-image imgauto\" >\n            <a href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/prevention-treatment-of-a-non-serious-dermatological-condition-on-the-foot\/\">\n        <img decoding=\"async\" width=\"200\" height=\"100\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/non-serious-dermatological-condition-foot.jpg\" class=\"attachment-wpm_taille_slider size-wpm_taille_slider wp-post-image\" alt=\"Prevention &amp; Treatment of a non-serious dermatological condition on the foot\" \/>            <\/a>\n    <\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:56%\">\n<h3 class=\"wp-block-getwid-template-post-title\"><a class=\"wp-block-getwid-template-post-title__link\" href=\"https:\/\/www.icta.fr\/fr\/cas-clients\/prevention-treatment-of-a-non-serious-dermatological-condition-on-the-foot\/\">Prevention &amp; Treatment of a non-serious dermatological condition on the foot<\/a><\/h3>\n\n\n<div class=\"wp-block-getwid-template-post-content is-excerpt\" ><p><\/p><\/div>\n\n\n<\/div>\n<\/div>\n<\/div><\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t            <\/div>\n\n                    <\/div>\n        <\/div><\/section>\n\n\n\n<section class=\"wp-block-uagb-section uagb-section__wrap uagb-section__background-color uagb-block-18300927\"><div class=\"uagb-section__overlay\"><\/div><div class=\"uagb-section__inner-wrap\">\n<div class=\"wp-block-columns container is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" width=\"126\" height=\"126\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/tampon-conformite-rgpd.png\" alt=\"RGPD compliant\" class=\"wp-image-143\" style=\"width:200px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img decoding=\"async\" width=\"122\" height=\"122\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/21cfr.png\" alt=\"21 CFR Part 11 compliance\" class=\"wp-image-144\" style=\"width:200px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" width=\"1200\" height=\"1200\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/Design-sans-titre-3.png\" alt=\"ecovadis 2024 bronze\" class=\"wp-image-10802\" style=\"width:200px\" srcset=\"https:\/\/www.icta.fr\/wp-content\/uploads\/Design-sans-titre-3.png 1200w, https:\/\/www.icta.fr\/wp-content\/uploads\/Design-sans-titre-3-300x300.png 300w, https:\/\/www.icta.fr\/wp-content\/uploads\/Design-sans-titre-3-1024x1024.png 1024w, https:\/\/www.icta.fr\/wp-content\/uploads\/Design-sans-titre-3-768x768.png 768w\" sizes=\"(max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image is-resized\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"800\" height=\"800\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/logo-agree-cir.png\" alt=\"cr\u00e9dit d'imp\u00f4t recherche\" class=\"wp-image-5987\" style=\"width:200px\" srcset=\"https:\/\/www.icta.fr\/wp-content\/uploads\/logo-agree-cir.png 800w, https:\/\/www.icta.fr\/wp-content\/uploads\/logo-agree-cir-300x300.png 300w, https:\/\/www.icta.fr\/wp-content\/uploads\/logo-agree-cir-768x768.png 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" width=\"150\" height=\"77\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/BV_Certification_ISO27001-3.jpg\" alt=\"bureau veritas certification icta\" class=\"wp-image-5968\" style=\"width:200px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" width=\"150\" height=\"71\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/BV_Certification_ISO-9001-2015-1.jpg\" alt=\"bureau veritas certification icta\" class=\"wp-image-5969\" style=\"width:200px\"\/><\/figure>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img decoding=\"async\" width=\"669\" height=\"651\" src=\"https:\/\/www.icta.fr\/wp-content\/uploads\/CDP2024.jpg\" alt=\"\" class=\"wp-image-10125\" style=\"width:200px\" srcset=\"https:\/\/www.icta.fr\/wp-content\/uploads\/CDP2024.jpg 669w, https:\/\/www.icta.fr\/wp-content\/uploads\/CDP2024-300x292.jpg 300w\" sizes=\"(max-width: 669px) 100vw, 669px\" \/><\/figure>\n<\/div><\/div>\n<\/div>\n<\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":3711,"parent":0,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"typewhite.php","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","inline_featured_image":false,"_uag_custom_page_level_css":"","kk_blocks_editor_width":"","_kiokenblocks_attr":"","_kiokenblocks_dimensions":"","footnotes":""},"class_list":["post-778","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"uagb_featured_image_src":{"full":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau.png",2732,324,false],"thumbnail":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-128x88.png",128,88,true],"medium":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-300x36.png",300,36,true],"medium_large":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-768x91.png",768,91,true],"large":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-1024x121.png",1024,121,true],"1536x1536":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-1536x182.png",1536,182,true],"2048x2048":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-2048x243.png",2048,243,true],"post-thumbnail":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-1568x186.png",1568,186,true],"wpm_taille_1":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-364x257.png",364,257,true],"wpm_taille_slider":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau-240x145.png",240,145,true],"gform-image-choice-sm":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau.png",300,36,false],"gform-image-choice-md":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau.png",400,47,false],"gform-image-choice-lg":["https:\/\/www.icta.fr\/wp-content\/uploads\/etudes-de-cas-icta-bandeau.png",600,71,false]},"uagb_author_info":{"display_name":"ictvsi6372","author_link":"https:\/\/www.icta.fr\/fr\/author\/jhvision-icta\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages\/778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/comments?post=778"}],"version-history":[{"count":20,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages\/778\/revisions"}],"predecessor-version":[{"id":9668,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/pages\/778\/revisions\/9668"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/media\/3711"}],"wp:attachment":[{"href":"https:\/\/www.icta.fr\/fr\/wp-json\/wp\/v2\/media?parent=778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}